13D Filing: Longitude Capital Partners, LLC and Corcept Therapeutics Inc (CORT)

Page 10 of 10

Page 10 of 10 – SEC Filing

Page
10 of 10 Pages

SCHEDULE A

Name of Reporting Person Date of
Transaction
No. of Shares Sale Price Per
Share of
Common Stock
LVP 05/25/2017 66,987 $ 12.0785 (1)
LCA 05/25/2017 1,343 $ 12.0785 (1)
LVP 05/30/2017 980,350 $ 10.90
LCA 05/30/2017 19,650 $ 10.90
LVP 06/07/2017 2,941,050 $ 11.73
LCA 06/07/2017 58,950 $ 11.73

_____________

(1) Reflects the weighted-average sale price, for multiple transactions executed at prices ranging from $11.60 to $12.30 per share.
The Reporting Persons hereby undertake to provide upon request to the Commission staff, the Issuer or a security holder of the
Issuer full information regarding the number of shares and prices at which the sales were effected.

Follow Corcept Therapeutics Inc (NASDAQ:CORT)

Page 10 of 10